By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Teva Pharmaceutical Industries Limited 

5 Basel Street

Petach Tikva    49131  Israel
Phone: 972-3-9267-267 Fax: 972-3-9234-050


Teva Pharmaceutical Industries Ltd. develops, produces and markets ethical drugs, generic drugs, and fine chemicals for the pharmaceutical industry and disposable products for hospitals and home care services.




Founders: Chaim Salomon, Moshe Levin, and Yitschak Elstein

CEO: Erez Vigodman

CEO Global Operations: Carlo de Notaristefani

CEO Global Specialty Medicines: Rob Koremans

CEO Global Generic Medicines: Sigudur (Siggi) Olafsson

CFO: Eyal Desheh

CMO (Medical):

CSO (Scientific): Michael Hayden


Please click here for Teva Pharma job opportunities.


Please click here for clinical trial information.


All Products

Key Statistics

Ownership: Public

Web Site: Teva
Employees: 5,700
Symbol: TEVA


Company News
Teva (TEVA) Stock Plummets After Two Patents are Invalidated by Mylan (MYL) 8/25/2016 6:08:44 AM
European Commission (EC) Grants Marketing Authorization For Teva (TEVA)’s CINQAERO (Reslizumab) 8/18/2016 9:35:36 AM
Teva (TEVA) Announces Launch Of Generic Gleevec Tablets In The United States 8/5/2016 11:01:51 AM
Mayne Pharma Commits $80 Million to North Carolina Expansion After Acquiring 42 Products from Allergan (AGN), Teva (TEVA) 8/4/2016 6:48:20 AM
Allergan (AGN) Completes Divestiture Of Global Generics Business To Teva (TEVA) 8/3/2016 12:13:18 PM
Teva (TEVA) Coughs Up $500 Million for Allergan (AGN)'s Distribution Biz 8/3/2016 6:22:33 AM
Teva (TEVA) Initiates Voluntary Nationwide Recall Of Seven Lots Of Amikacin Sulfate Injection USP 500mg/2 Ml (250 Mg/Ml) And 1 Gram/4 Ml (250 Mg/Ml) Vials Due To Potential Of Glass Particulate Matter 7/29/2016 10:27:19 AM
Teva (TEVA) To Report Second Quarter 2016 Financial Results On August 4, 2016 7/28/2016 10:46:56 AM
Clinton Running Mate Tim Kaine Scrutinized for Private Plane Ride Provided by Teva (TEVA) Subsidiary 7/26/2016 7:38:39 AM
Following Revelations of ‘Flawed Studies’ in Clinical Trials, EMA Recommends Suspending Drugs; Many of Which Belong to Novartis AG (NVS) and Teva (TEVA) 7/25/2016 6:50:43 AM